Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Simona Ferraiuolo"'
Autor:
Sabino Strippoli, Annarita Fanizzi, Davide Quaresmini, Annalisa Nardone, Andrea Armenio, Francesco Figliuolo, Raffaele Filotico, Livia Fucci, Fabio Mele, Michele Traversa, Federica De Luca, Elisabetta Sara Montagna, Eustachio Ruggieri, Simona Ferraiuolo, Francesco Macina, Stefania Tommasi, Angela Monica Sciacovelli, Ivana De Risi, Anna Albano, Raffaella Massafra, Michele Guida
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundCutaneous squamous cell carcinoma (CSCC) is the second most common skin cancer whose incidence is growing parallel to the lengthening of the average lifespan. Cemiplimab, an antiPD-1 monoclonal antibody, is the first approved immunotherapy
Externí odkaz:
https://doaj.org/article/e3cb353df58947c7904f8a685506ef5d
Autor:
Antonella Argentiero, Antonio Giovanni Solimando, Valentina Ungaro, Mariarita Laforgia, Sabino Strippoli, Dario Pinto, Antonio Negri, Simona Ferraiuolo, Alfredo Zito, Michele Guida
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Recent advances in tumor immunotherapy have made it possible to efficiently unleash immune effectors, reacting against neoplastic cells. Although these approaches primarily aim to eradicate malignancy, immune-related adverse events (irAEs) often infl
Externí odkaz:
https://doaj.org/article/3082fae629c74b70b84b357fc7b3034c
Autor:
Angela Monica Sciacovelli, Elisabetta Sara Montagna, Francesco Macina, Annalisa Nardone, Raffaella Massafra, Anna Albano, Simona Ferraiuolo, Eustachio Ruggieri, Livia Fucci, Stefania Tommasi, Andrea Armenio, Federica De Luca, Ivana De Risi, Raffaele Filotico, Michele Guida, Davide Quaresmini, Francesco Figliuolo, Annarita Fanizzi, Michele Traversa, Sabino Strippoli, Fabio Mele
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology
Frontiers in Oncology
BackgroundCutaneous squamous cell carcinoma (CSCC) is the second most common skin cancer whose incidence is growing parallel to the lengthening of the average lifespan. Cemiplimab, an antiPD-1 monoclonal antibody, is the first approved immunotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcb418746950eac69ba6b54b43a53b68
https://www.frontiersin.org/articles/10.3389/fonc.2021.686308/full
https://www.frontiersin.org/articles/10.3389/fonc.2021.686308/full
Autor:
Simona Ferraiuolo, Patrizia Nardulli, Carmelo Laface, Concetta Calabrò, Valentina Ungaro, Mariarita Laforgia, Domenico Tricarico, Girolamo Ranieri, Cosmo Damiano Gadaleta
Publikováno v:
International Journal of Molecular Sciences
International Journal of Molecular Sciences, Vol 22, Iss 1980, p 1980 (2021)
International Journal of Molecular Sciences, Vol 22, Iss 1980, p 1980 (2021)
Peripheral neurologic complications are frequent adverse events during oncologic treatments and often lead to dose reduction, administration delays with time elongation of the therapeutic plan and, not least, worsening of patients’ quality of life.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9219febd207605dbb63a48a15cfde692
http://europepmc.org/articles/PMC7922628
http://europepmc.org/articles/PMC7922628
Autor:
Patrizia Nardulli, Simona Ferraiuolo, Ilaria Marech, Cosmo Damiano Gadaleta, Pasquale Molinari, Girolamo Ranieri, Mariarita Laforgia
Publikováno v:
Cancers
Cancers, Vol 11, Iss 2, p 141 (2019)
Cancers, Vol 11, Iss 2, p 141 (2019)
Liver metastases (LM) are often consequences of colo-rectal cancer (CRC)and the majority of patients have unresectable LM. Oxaliplatin-based intravenous chemotherapy represents the gold standard treatment for CRC. Intravenous oxaliplatin has several
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f8c5260290fc8cb85cc1a3c83afeb57a
https://doi.org/10.3390/cancers11020141
https://doi.org/10.3390/cancers11020141
Autor:
Maria Rita Laforgia, Patrizia Nardulli, Maria Grazia Perrone, Simona Ferraiuolo, Nicola Antonio Colabufo, Elena Capparelli, Claudia Crapolicchio
Publikováno v:
Journal of Pharmacovigilance.
Objectives A longer postoperative care, needed for patients admitted to the hospital, is expensive and associated with increased morbidity and mortality, when compared with the outpatient setting. Outpatient therapy with continuous infusion of drugs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::00371b8f075ae061c006025388559e0c
https://doi.org/10.4172/2329-6887.1000157
https://doi.org/10.4172/2329-6887.1000157